Myrtillin as a Promising Immunomodulator: Molecular Modeling and Pharmacokinetic Evaluation

Authors

• Adolat Manakbayeva, Research and Production Center for Microbiology and Virology
• Timur Kerimov, Research and Production Center for Microbiology and Virology
• I D. Ershov, Research and Production Center for Microbiology and Virology
• E. I. Anarkulova, Research and Production Center for Microbiology and Virology
• Pavel Alexyuk, Research and Production Center for Microbiology and Virology
• Y Moldakhanov, Research and Production Center for Microbiology and Virology
• Ahdrey P. Bogoyavlenskiy, Research and Production Center for Microbiology and Virology
• Vyacheslav Dushenkov, CUNY Hostos Community CollegeFollow

Document Type

Article

Publication Date

2025

Abstract

Myrtillin, an anthocyanin found in blueberry fruits, is known for its antioxidant and potentially immunomodulatory properties. In this study, molecular docking was used to evaluate its interactions with a wide panel of immune-related proteins, including pro-inflammatory cytokines (TNF-α, IL-6, IL-17), antiinflammatory mediators (IL-4, IL-10), and signaling pathway proteins (1NFK, p52/RelB). The in silico results were supported by interaction analysis, and an ADMET analysis was conducted to assess the pharmacokinetic and toxicological profile. The findings confirm the promise of Myrtillin as a natural modulator of inflammatory responses.

Comments

Sugested citation: 

Manakbayeva, A. N.; Kerimov, T. T.; Ershov, I. D.; Anarkulova, E. I.; Alexyuk, P.; Moldakhanov, Y.; Bogoyavlenskiy, A.; Dushenkov, V. M. Myrtillin as a Promising Immunomodulator: Molecular Modeling and Pharmacokinetic Evaluation. Microbiology and Virology 2025, 3 (50), 309-325. DOI: doi:10.53729/MV-AS.2025.03.17.